Conditional glucagon receptor overexpression has multi-faceted consequences for beta-cell function

Metabolism: Clinical and Experimental

Volumn 63, Issue 12, 2014, Pages 1568-1576

  Omar, Bilal ^a   Sörhede Winzell, Maria ^a   Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Beta cell function; GLP 1; Glucagon; Insulin

Indexed keywords

ARGININE; CARBACHOL; CYCLIC AMP; FORSKOLIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON RECEPTOR; GLUCOSE; INSULIN; ANTIDIABETIC AGENT; MUSCARINIC RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BODY WEIGHT; CELLULAR SECRETION; CONTROLLED STUDY; DIET RESTRICTION; FOOD INTAKE; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN RESPONSE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; GLUCOSE TOLERANCE TEST; HUMAN; METABOLISM; PANCREAS ISLET; TRANSGENIC MOUSE;

ANIMALS; ARGININE; BODY WEIGHT; CARBACHOL; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; RECEPTORS, GLUCAGON; RECEPTORS, MUSCARINIC;

EID: 84922214486     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.09.004     Document Type: Article

References (22)

1. J.C. Henquin, D. Accili, B. Ahren, C. Boitard, S. Seino, and E. Cerasi Long in the shade, glucagon re-occupies centre court Diabetes Obes Metab 13 Suppl. 1 2011 v viii
2. N. Abrahamsen, and E. Nishimura Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids Endocrinology 136 1995 1572 1578
3. E. Yamato, H. Ikegami, and K. Takekawa Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1) Horm Metab Res 29 1997 56 59
4. L. Portois, M. Tastenoy, B. Viollet, and M. Svoboda Functional analysis of the glucose response element of the rat glucagon receptor gene in insulin-producing INS-1 cells Biochim Biophys Acta 1574 2002 175 186
5. W.A. Muller, G.R. Faloona, and R.H. Unger The effect of experimental insulin deficiency on glucagon secretion J Clin Invest 50 1971 1992 1999
6. R.W. Gelling, P.M. Vuguin, and X.Q. Du Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass Am J Physiol Endocrinol Metab 297 2009 E695 E707
7. B. Ahren, and G. Pacini Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice Am J Physiol 277 1999 E996 E1004
8. G. Pacini, K. Thomaseth, and B. Ahren Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice Am J Physiol Endocrinol Metab 281 2001 E693 E703
9. R.H. Unger, and A.D. Cherrington Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover J Clin Invest 122 2012 4 12
10. P. Huypens, Z. Ling, D. Pipeleers, and F. Schuit Glucagon receptors on human islet cells contribute to glucose competence of insulin release Diabetologia 43 2000 1012 1019
11. F.K. Knop, T. Vilsboll, S. Madsbad, J.J. Holst, and T. Krarup Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus Diabetologia 50 2007 797 805
12. G. Xu, H. Kaneto, and D.R. Laybutt Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes Diabetes 56 2007 1551 1558
13. L. Shu, A.V. Matveyenko, J. Kerr-Conte, J.H. Cho, C.H. McIntosh, and K. Maedler Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function Hum Mol Genet 18 2009 2388 2399
14. J. Taneera, S. Lang, and A. Sharma A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets Cell Metab 16 2012 122 134
15. E. Hall, T. Dayeh, C.L. Kirkpatrick, C.B. Wollheim, M. Dekker Nitert, and C. Ling DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets BMC Med Genet 14 2013 76
16. P.V. Hojberg, T. Vilsboll, and R. Rabol Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes Diabetologia 52 2009 199 207
17. Z. An, R.L. Prigeon, and D.A. D'Alessio Improved glycemic control enhances the incretin effect in patients with type 2 diabetes J Clin Endocrinol Metab 98 2013 4702 4708
18. H.C. Fehmann, A. Pracht, and B. Goke High-level expression of the GLP-I receptor results in receptor desensitization Pancreas 17 1998 309 314
19. H.C. Fehmann, R. Goke, B. Goke, and R. Arnold Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreas Z Gastroenterol 28 1990 348 352
20. N. Ishiyama, M.A. Ravier, and J.C. Henquin Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets Am J Physiol Endocrinol Metab 290 2006 E540 E549
21. W.S. Zawalich, K.C. Zawalich, and G.G. Kelley Regulation of insulin release by phospholipase C activation in mouse islets: differential effects of glucose and neurohumoral stimulation Endocrinology 136 1995 4903 4909
22. P.A. Smith, H. Sakura, B. Coles, N. Gummerson, P. Proks, and F.M. Ashcroft Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic beta-cells J Physiol 499 Pt 3 1997 625 635